Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Batu, EZGİ; Sonmez, HAFİZE; HAZIROLAN, TUNCAY; ÖZALTIN, FATİH; BİLGİNER, YELDA; ÖZEN, SEZA

doi:10.1016/j.semarthrit.2016.07.012

Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Atıf İçin Kopyala

Batu E. D., Sonmez H. E., HAZIROLAN T., ÖZALTIN F., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM, cilt.46, sa.4, ss.529-535, 2017 (SCI-Expanded)

Yayın Türü: Makale / Derleme
Cilt numarası: 46 Sayı: 4
Basım Tarihi: 2017
Doi Numarası: 10.1016/j.semarthrit.2016.07.012
Dergi Adı: SEMINARS IN ARTHRITIS AND RHEUMATISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.529-535
Anahtar Kelimeler: Child, Takayasu arteritis, Tocilizumab, Treatment, RHEUMATOLOGY 1990 CRITERIA, DISEASE-ACTIVITY, TNF-ALPHA, CLASSIFICATION, CHILDREN, EFFICACY, INTERLEUKIN-6, VASCULITIS
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Our aim was to describe our experience with tocilizumab (interleukin 6 receptor antagonist) treatment in children with Takayasu arteritis and to review previous studies regarding tocilizumab use in Takayasu arteritis patients.